Presentation TCT 2016 Strengths and Limitations of OCT to Detect Vulnerable Plaque: A Critical Appraisal Presenter: John A. Ambrose, Peter H. Stone, Guillermo Tearney November 01, 2016
Presentation TCT 2016 Editorial Perspective: Given DCB Results, Is There Any Role for Stenting or Atherectomy in SFA Intervention? Presenter: Koen Deloose, William A. Gray, Lawrence A. Garcia November 01, 2016
Presentation TCT 2016 Announcing the NIH-sponsored HYBRID Revascularization Trial Presenter: John D. Puskas, Gregg W. Stone November 01, 2016
Presentation TCT 2016 2016 DAPT Update: Evidence and Guidelines Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla November 01, 2016
Presentation TCT 2016 Impact of SFA Lesion Complexity: DCB Outcomes in the "Real-world" Presenter: Koen Deloose, William A. Gray November 01, 2016
Presentation TCT 2016 NIRS Detection of Vulnerable Plaque: The Story Is Intensifying Presenter: John A. Ambrose, Peter H. Stone, David Erlinge November 01, 2016
Presentation TCT 2016 Preprocedural Planning Prior to Transcatheter Mitral Valve Interventions Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min November 01, 2016
Presentation TCT 2016 When to Stop Being an Interventionalist: Age Alone? Presenter: David O. Williams, Augusto D. Pichard November 01, 2016
Presentation TCT 2016 How Much Radiation Do I Use Compared to Others? Review of Reference Levels and QA Policies Presenter: Stephen Balter, Donald L. Miller November 01, 2016
Presentation TCT 2016 Hot Topic #2: Lipid Lowering Targets and the Potential Role of the PSCK9 Inhibitors in Routine Clinical Practice Presenter: Bernard J. Gersh, Felix Mahfoud, Evan A. Stein November 01, 2016